Omidria lessens risk for intraoperative IFIS

Patients who received Omidria during cataract surgery experienced significantly less miosis, pupil billowing and incidence of iris prolapse, all characteristics of intraoperative floppy iris syndrome.
A prospective study evaluating the effect of Omidria (phenylephrine 1% and ketorolac 0.3% intraocular solution, Omeros) during cataract surgery in male patients on tamsulosin found the drug greatly reduced the risk for intraoperative floppy iris syndrome (IFIS) symptoms.
Male patients treated with tamsulosin, an alpha-1 receptor antagonist that blocks symptoms of benign prostatic hypertrophy,

Full Story →